MedTrace Logo

A Pilot Clinical Trial of Oral Ketamine for Acute Pain Management After Amputation Surgery

NCT02341963 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2021-03-01

No results posted yet for this study

Summary

The purpose of this pilot study is to test the safety of oral ketamine to treat acute pain after amputation surgery. The objective of the proposed research is to conclusively determine if oral ketamine is a safe alternative analgesic to opioid for acute pain in subjects undergoing elective amputation of the lower extremity. All participants will receive oral ketamine.

Conditions

  • Acute Pain Management
  • Analgesic, Nonopioid
  • Amputation of Lower Extremity, All Causes

Interventions

DRUG

Oral Ketamine

Oral ketamine (Ketamine HCL injection, 100 mg/ml, USP, Hospira)

Sponsors & Collaborators

  • Rush University Medical Center

    lead OTHER

Principal Investigators

  • Asokumar Buvanendran, M.D. · Professor Anesthesiology, Rush Unviersity Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2020-12-31
Completion
2021-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02341963 on ClinicalTrials.gov